High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models
抗 BCMA 同种异体 CAR T 细胞中的高特异性 CRISPR 介导基因组工程可抑制临床前模型中的同种异体移植排斥
期刊:Cancer Immunology Research
影响因子:8.1
doi:10.1158/2326-6066.CIR-23-0679
Émilie Degagné, Paul D Donohoue, Suparna Roy, Jessica Scherer, Tristan W Fowler, Ryan T Davis, Gustavo A Reyes, George Kwong, Morena Stanaway, Vanina Larroca Vicena, Devin Mutha, Raymond Guo, Leslie Edwards, Benjamin Schilling, McKay Shaw, Stephen C Smith, Bryan Kohrs, Heinrich J Kufeldt, Glen Churc
